MARLBOROUGH, Mass.,
July 30, 2018 /PRNewswire/ -- Boston
Scientific Corporation (NYSE: BSX) is scheduled to participate in
the 38th Annual Canaccord Genuity Growth Conference on
Wednesday, August 8, 2018 in
Boston.
Susie Lisa, vice president,
Investor Relations, and Lindsay
Fish, director, Investor Relations, will participate in a
25-minute question-and-answer session with the host analyst
beginning at approximately 9:00 a.m.
EDT. A live webcast of the session will be available on the
Investor Relations section of the Boston Scientific website at
investors.bostonscientific.com. A replay of the webcast will be
accessible at investors.bostonscientific.com beginning
approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 35 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Kate
Haranis
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Kate_Haranis@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-38th-annual-canaccord-genuity-growth-conference-300688517.html
SOURCE Boston Scientific Corporation